Proteomic Differences in Normal and Glaucomatous Optic Nerve
About the Research Project
Program
Award Type
Standard
Award Amount
$90,000
Active Dates
April 01, 2005 - March 31, 2007
Grant ID
G2005047
Summary
Dr. Bhattacharya believes there are intrinsic differences in protein composition in the optic nerve that put the individuals at increased risk to glaucoma and that protein modifications leads to progression of the disease. The specific aim of this project is to determine the differential protein profile between a normal and glaucomatous optic nerve and to confirm the identity of unique glaucoma-associated proteins. The identification of proteins and protein modifications may serve as markers for individuals predisposed to an increased risk of developing glaucoma. Such information will provide insight into the causes of glaucoma and lead to identification of possible drug targets for glaucoma therapy.
Grantee institution at the time of this grant: Cleveland Clinic Foundation
Related Grants
National Glaucoma Research
From Resilience to Vulnerability: How Stress Accelerates Aging
Active Dates
July 01, 2025 - June 30, 2027
Principal Investigator
Dorota Skowronska-Krawczyk, PhD
Current Organization
University Of California, Irvine
From Resilience to Vulnerability: How Stress Accelerates Aging
Active Dates
July 01, 2025 - June 30, 2027
Principal Investigator
Dorota Skowronska-Krawczyk, PhD
Current Organization
University Of California, Irvine
National Glaucoma Research
Novel Mechanisms to Regulate Eye Pressure
Active Dates
July 01, 2025 - June 30, 2027
Principal Investigator
Colleen McDowell, PhD
Current Organization
University of Wisconsin-Madison
Novel Mechanisms to Regulate Eye Pressure
Active Dates
July 01, 2025 - June 30, 2027
Principal Investigator
Colleen McDowell, PhD
Current Organization
University of Wisconsin-Madison
National Glaucoma Research
Developing a New Glaucoma Treatment That Avoids Daily Drops
Active Dates
July 01, 2025 - June 30, 2027
Principal Investigator
Gavin Roddy, MD, PhD
Current Organization
Mayo Clinic, Rochester
Developing a New Glaucoma Treatment That Avoids Daily Drops
Active Dates
July 01, 2025 - June 30, 2027
Principal Investigator
Gavin Roddy, MD, PhD
Current Organization
Mayo Clinic, Rochester